Metabolic cooperation between different oncogenes during cell transformation:: interaction between activated ras and HPV-16 E7

被引:95
作者
Mazurek, S
Zwerschke, W
Jansen-Dürr, P
Eigenbrodt, E
机构
[1] Univ Giessen, Fac Vet, Inst Biochem & Endocrinol, D-35392 Giessen, Germany
[2] Austrian Acad Sci, Inst Biomed Ageing Res, A-6020 Innsbruck, Austria
[3] Tyrolean Canc Res Inst, A-6020 Innsbruck, Austria
基金
奥地利科学基金会;
关键词
metabolome; glycolysis; glutaminolysis; M2-PK; adenylate kinase; nucleotides;
D O I
10.1038/sj.onc.1204792
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The metabolism of tumor cells (tumor metabolome) is characterized by a high concentration of glycolytic enzymes including pyruvate kinase isoenzyme type M2 (M2-PK), a high glutaminolytic capacity, high fructose 1,6-bisphosphate (FBP) levels and a low (ATP + GTP):(CTP+UTP) ratio. The sequence of events required for the establishment of the tumor metabolome is presently unknown. In non-transformed rat kidney (NRK) cells we observed a high glutaminolytic flux rate and a low (ATP + GTP):(CTP + UTP) ratio, whereas FBP levels and M2-PK activity are still extremely low. After stable expression of oncogenic ras in NRK cells a strong upregulation of FBP levels and of M2-PK activity was observed. Elevated FBP levels induce a tetramerization of M2-PK and its migration into the glycolytic enzyme complex. AMP levels increase whereas UTP and CTP levels strongly decrease. Thus, ras expression completes the glycolytic part of tumor metabolism leading to the inhibition of nucleic acid synthesis and cell proliferation. The HPV-16 E7 oncoprotein, which cooperates with ras in cell transformation, directly binds to M2-PK, induces its dimerization and restores nucleic acid synthesis as well as cell proliferation. Apparently, the combination of the different metabolic effects of ras and E7 constructs the perfect tumor metabolome as generally found in tumor cells.
引用
收藏
页码:6891 / 6898
页数:8
相关论文
共 52 条
[11]   Oncogenic alterations of metabolism [J].
Dang, CV ;
Semenza, GL .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) :68-72
[12]  
Downes CS, 2000, J CELL SCI, V113, P1089
[13]   CHARACTERIZATION OF A HEPATOMA MESSENGER-RNA TRANSCRIBED FROM A 3RD PROMOTER OF A 6-PHOSPHOFRUCTO-2-KINASE FRUCTOSE-2,6-BISPHOSPHATASE-ENCODING GENE AND CONTROLLED BY ETS ONCOGENE-RELATED PRODUCTS [J].
DUPRIEZ, VJ ;
DARVILLE, MI ;
ANTOINE, IV ;
GEGONNE, A ;
GHYSDAEL, J ;
ROUSSEAU, GG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8224-8228
[14]  
EIGENBRODT E, 1992, Critical Reviews in Oncogenesis, V3, P91
[15]  
Eigenbrodt E, 1998, ANTICANCER RES, V18, P3267
[16]  
EIGENBRODT E, 1998, CELL GROWTH ONCOGENE, P15
[17]  
EIGENBRODT E, 1985, REGULATION CARBOHYDR, P141
[18]   Taxol (paclitaxel) induces a detachment of phosphofructokinase from cytoskeleton of melanoma cells and decreases the levels of glucose 1,6-bisphosphate, fructose 1,6-bisphosphate and ATP [J].
Glass-Marmor, L ;
Beitner, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 370 (02) :195-199
[19]   ASSOCIATION OF THE SRC-GENE PRODUCT OF ROUS-SARCOMA VIRUS WITH A PYRUVATE-KINASE INACTIVATING FACTOR [J].
GLOSSMANN, H ;
PRESEK, P ;
EIGENBRODT, E .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1981, 23 (01) :49-63
[20]   GLYCOLYTIC ENZYME-ACTIVITIES IN MURINE SARCOMA VIRUS-TRANSFORMED CULTURES OF BALB 3T3 - ROLE OF CULTURE DENSITY [J].
GREGORY, SH ;
KUMARI, HL ;
LAKSHMI, MV ;
BOSE, SK .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1976, 175 (02) :644-653